25th Jan 2016 07:00
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
25 January 2016
Constellation Healthcare Technologies, Inc.
("Constellation" or "the Company")
Trading update
Further to the announcement made on 19 November 2015, Constellation Healthcare Technologies, the US-based healthcare services and technology Company, is pleased to provide the following trading update for the year ended 31 December 2015. Based on unaudited management information the Company finished the year with revenue of approximately $76M and EBITDA of approximately $23M. The Company expects to report its audited results in due course.
Paul Parmar, Chief Executive Officer of Constellation, commented, "2015 has been a very busy and successful year for Constellation and this is reflected in our financial performance. We have achieved year-on-year revenue and EBITDA growth of 35% and 62% respectively. We look forward to 2016 with confidence when we will continue to deliver on our strategy as we strive to become one of the largest scaled platforms in the US healthcare and technology sector".
Enquiries:
Constellation Healthcare Technologies Paul Parmar, Chief Executive Officer Sotirios ("Sam") Zaharis, Chief Financial Officer | c/o Redleaf +44 (0)20 7382 4730 |
finnCap - Nominated Adviser and Joint Broker Julian Blunt / Scott Mathieson
| +44 (0)20 7220 0500 |
Stifel - Joint Broker Jonathan Senior / Ben Maddison | +44 (0)20 7710 7600 |
Redleaf Communications - PR adviser Charlie Geller / Harriet Lynch
|
+44 (0)20 7382 4730 |
Related Shares:
CHT.L